Your browser doesn't support javascript.
Cryptic transmission of SARS-CoV-2 in Washington state.
Bedford, Trevor; Greninger, Alexander L; Roychoudhury, Pavitra; Starita, Lea M; Famulare, Michael; Huang, Meei-Li; Nalla, Arun; Pepper, Gregory; Reinhardt, Adam; Xie, Hong; Shrestha, Lasata; Nguyen, Truong N; Adler, Amanda; Brandstetter, Elisabeth; Cho, Shari; Giroux, Danielle; Han, Peter D; Fay, Kairsten; Frazar, Chris D; Ilcisin, Misja; Lacombe, Kirsten; Lee, Jover; Kiavand, Anahita; Richardson, Matthew; Sibley, Thomas R; Truong, Melissa; Wolf, Caitlin R; Nickerson, Deborah A; Rieder, Mark J; Englund, Janet A; Hadfield, James; Hodcroft, Emma B; Huddleston, John; Moncla, Louise H; Müller, Nicola F; Neher, Richard A; Deng, Xianding; Gu, Wei; Federman, Scot; Chiu, Charles; Duchin, Jeffrey S; Gautom, Romesh; Melly, Geoff; Hiatt, Brian; Dykema, Philip; Lindquist, Scott; Queen, Krista; Tao, Ying; Uehara, Anna; Tong, Suxiang.
  • Bedford T; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. tbedford@fredhutch.org.
  • Greninger AL; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.
  • Roychoudhury P; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Starita LM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Famulare M; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Huang ML; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Nalla A; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Pepper G; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.
  • Reinhardt A; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Xie H; Institute for Disease Modeling, Bellevue, WA, USA.
  • Shrestha L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Nguyen TN; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Adler A; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Brandstetter E; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Cho S; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Giroux D; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Han PD; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Fay K; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.
  • Frazar CD; Division of Infectious Disease, Seattle Children's Hospital, Seattle, WA, USA.
  • Ilcisin M; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
  • Lacombe K; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.
  • Lee J; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Kiavand A; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Richardson M; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.
  • Sibley TR; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Truong M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Wolf CR; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Nickerson DA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Rieder MJ; Division of Infectious Disease, Seattle Children's Hospital, Seattle, WA, USA.
  • Englund JA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Hadfield J; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Hodcroft EB; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Huddleston J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Moncla LH; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.
  • Müller NF; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Neher RA; Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA, USA.
  • Deng X; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.
  • Gu W; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Federman S; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.
  • Chiu C; Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  • Duchin JS; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.
  • Gautom R; Division of Infectious Disease, Seattle Children's Hospital, Seattle, WA, USA.
  • Melly G; Department of Pediatrics, University of Washington, Seattle, WA, USA.
  • Dykema P; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Lindquist S; Biozentrum, University of Basel, Basel, Switzerland.
  • Queen K; Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  • Tao Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Uehara A; Molecular and Cellular Biology Program, University of Washington, Seattle, WA, USA.
  • Tong S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Science ; 370(6516): 571-575, 2020 10 30.
Artículo en Inglés | MEDLINE | ID: covidwho-760213
Preprint
Este artículo de revista científica es probablemente basado en un preprint previamente disponible, por medio del reconocimiento de similitud realizado por una máquina. La confirmación humana aún está pendiente.
Ver preprint
ABSTRACT
After its emergence in Wuhan, China, in late November or early December 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus rapidly spread globally. Genome sequencing of SARS-CoV-2 allows the reconstruction of its transmission history, although this is contingent on sampling. We analyzed 453 SARS-CoV-2 genomes collected between 20 February and 15 March 2020 from infected patients in Washington state in the United States. We find that most SARS-CoV-2 infections sampled during this time derive from a single introduction in late January or early February 2020, which subsequently spread locally before active community surveillance was implemented.
Asunto(s)

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Genoma Viral / Infecciones por Coronavirus / Betacoronavirus Tipo de estudio: Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: Science Año: 2020 Tipo del documento: Artículo País de afiliación: Science.abc0523

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Genoma Viral / Infecciones por Coronavirus / Betacoronavirus Tipo de estudio: Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: Science Año: 2020 Tipo del documento: Artículo País de afiliación: Science.abc0523